Pegylated Interferon Alpha-1a bulk supplier for pharma manufacturers

Pegylated Interferon Alpha-1A 120 mcg, 150 mcg, 180 mcg Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 120 mcg, 150 mcg, 180 mcg

Reference Brands: Pegasys® (US & EU), PegIntron® (EU)

Category: Hepatitis

PegIntron® is a pegylated interferon alpha-2b injection used to treat chronic Hepatitis C. Available in 120, 150, and 180 mcg prefilled syringes, it’s given once weekly at 1.5 mcg/kg subcutaneously. Often combined with ribavirin, PegIntron® is manufactured to EU-GMP and USFDA standards, making it suitable for B2B supply, hospital tenders, and licensing in EU and US markets.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

PegIntron® is a pegylated interferon alpha-2b injection used for treating chronic Hepatitis C infection. It delivers a sustained antiviral effect by stimulating the immune response against the virus. Available in prefilled syringes with strengths of 120 mcg, 150 mcg, and 180 mcg, PegIntron® is administered once weekly via subcutaneous injection, typically dosed at 1.5 mcg/kg. Often combined with ribavirin, it is manufactured under EU-GMP and USFDA standards. PegIntron® is widely used in hospital tenders, B2B supply, and licensing with comprehensive regulatory dossiers to support market entry in EU and US.

Pegylated Interferon Alpha-1A — third party manufacturing & bulk supply

Pegylated Interferon Alpha-1A 120 mcg, 150 mcg, 180 mcg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Pegylated Interferon Alpha-1A is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Pegylated Interferon Alpha-1A listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Pegylated Interferon Alpha-1A →

Back to Listing

Frequently Asked Questions

Pegylated interferon alpha-1a is used for the treatment of certain chronic viral infections, particularly hepatitis B and hepatitis C, where it helps control viral replication and supports the immune system in fighting the infection. It works by enhancing the body’s natural antiviral response and regulating immune activity.

Pegylated interferon alpha-1a is a recombinant interferon protein produced through biotechnology using genetically engineered cells. It is chemically linked with polyethylene glycol (PEG), a process known as pegylation, which helps the medicine remain active in the body for a longer period.

A well-known trade name associated with pegylated interferon therapies is Pegasys.

Pegylated interferon products are manufactured by major biopharmaceutical companies such as Roche and other licensed biologics manufacturers depending on the market.

The generic name is Pegylated interferon alpha-1a.

One of the commonly known brand names in the pegylated interferon category is Pegasys.

Pegylated interferon alpha-1a is manufactured in regulated biopharmaceutical production facilities in countries such as Switzerland, the United States, and other regions that follow strict biologics manufacturing and quality standards.